eli lilly oral glp 1 stock soars on encouraging results for daily weight-loss pill Oral GLP-1 Orforglipron Is Approved
Description
Patients report increased self-confidence, reduced anxiety around food choices, and improved body image

Compounded alternatives and what changed in 20242025 During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of these molecules

Meanwhile, synthetic forms of GLP-1, like semaglutide and tirzepatide, are long acting it takes about seven days to break them down, hence the reason people take weekly injections and lead to significant weight loss

A systematic review and meta-analysis of 55 RCTs (106,395 participants) published in Gastroenterology in 2025 confirmed elevated risk of cholelithiasis, cholecystitis, and gastrointestinal events across the class

Compounded medications are not mass-produced and are not reviewed or approved by the FDA for safety or efficacy
